Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced anxiety disorder
Summary
This condition involves the use of sedative, hypnotic, or anxiolytic substances with an associated anxiety disorder caused by these substances. The pattern of use is not specified further, and the anxiety disorder is directly attributed to the effects of the substance. These drugs are commonly prescribed for anxiety, insomnia, or sedation but may lead to substance-induced anxiety when used.
Causes
The condition arises from the use of sedative, hypnotic, or anxiolytic drugs, such as benzodiazepines or barbiturates. The anxiety disorder is a direct result of the substance's effects on the central nervous system, and the unspecified nature indicates insufficient detail to classify the pattern of use beyond the presence of the induced anxiety.
Risk Factors
- Prolonged or excessive use of these medications
- History of substance use disorders
- Underlying mental health conditions (e.g., anxiety, depression)
- Easy access to sedative/hypnotic/anxiolytic drugs
- Recreational or non-medical use
Symptoms
- Variable depending on the context of use
- May include cravings, tolerance, or withdrawal symptoms if use is prolonged
- Anxiety symptoms directly attributable to the substance use
- No specific symptoms are required for this unspecified code
Diagnosis
Diagnosis is based on clinical evaluation of substance use history and assessment of the pattern of use. The presence of an anxiety disorder directly induced by sedative, hypnotic, or anxiolytic substances, with an unspecified pattern of use, is key to distinguishing this condition.
Treatment Options
- Addressing the underlying substance use
- Managing anxiety symptoms with non-pharmacological or alternative treatments
- Monitoring for potential misuse or dependence
- Education on safe medication use
Prognosis and Follow-Up
Prognosis depends on the resolution of substance use and management of anxiety symptoms. Follow-up may involve regular monitoring of substance use patterns and anxiety symptoms to prevent recurrence or escalation.
Complications
- Worsening of anxiety or substance use
- Development of dependence or withdrawal
- Interference with daily functioning
- Increased risk of other substance-related disorders
Lifestyle & Prevention
- Limiting or avoiding non-prescribed use of sedative, hypnotic, or anxiolytic drugs
- Using medications only as directed by a healthcare provider
- Seeking alternative treatments for anxiety or insomnia when possible
- Maintaining open communication with healthcare providers about substance use
When to Seek Professional Help
Seek professional help if anxiety symptoms persist or worsen, if substance use becomes difficult to control, or if there are signs of dependence or withdrawal.
Tips for Medical Coders
Document the presence of a sedative, hypnotic, or anxiolytic-induced anxiety disorder and note that the pattern of use is unspecified. Ensure clinical documentation supports the relationship between the substance use and the anxiety disorder to justify the code.
Medical Policies and Guidelines
Related policies from health plans
F13.980 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.